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Abstract
The osteoblast-lineage consists of cells at various stages of maturation that are essential for skeletal development, growth,
and maintenance. Over the past decade, many of the signaling cascades that regulate this lineage have been elucidated;
however, little is known of the networks that coordinate, modulate, and transmit these signals. Here, we identify a gene
network specific to the osteoblast-lineage through the reconstruction of a bone co-expression network using microarray
profiles collected on 96 Hybrid Mouse Diversity Panel (HMDP) inbred strains. Of the 21 modules that comprised the bone
network, module 9 (M9) contained genes that were highly correlated with prototypical osteoblast maker genes and were
more highly expressed in osteoblasts relative to other bone cells. In addition, the M9 contained many of the key genes that
define the osteoblast-lineage, which together suggested that it was specific to this lineage. To use the M9 to identify novel
osteoblast genes and highlight its biological relevance, we knocked-down the expression of its two most connected ‘‘hub’’
genes, Maged1 and Pard6g. Their perturbation altered both osteoblast proliferation and differentiation. Furthermore, we
demonstrated the mice deficient in Maged1 had decreased bone mineral density (BMD). It was also discovered that a local
expression quantitative trait locus (eQTL) regulating the Wnt signaling antagonist Sfrp1 was a key driver of the M9. We also
show that the M9 is associated with BMD in the HMDP and is enriched for genes implicated in the regulation of human BMD
through genome-wide association studies. In conclusion, we have identified a physiologically relevant gene network and
used it to discover novel genes and regulatory mechanisms involved in the function of osteoblast-lineage cells. Our results
highlight the power of harnessing natural genetic variation to generate co-expression networks that can be used to gain
insight into the function of specific cell-types.
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Introduction
The osteoblast-lineage consists of a spectrum of cells beginning
with osteoprogenitors derived from mesenchymal stem cells that
then differentiate to form mature bone-forming osteoblasts and
bone-lining cells. The final stage in the life-cycle of the lineage
occurs when a subset of mature osteoblasts become entombed in
bone as mechanosensitive osteocytes [1]. As the only known bone-
forming cell, osteoblasts are essential for skeletal development,
growth and maintenance [1]. In addition to their critical role in
the skeleton, osteoblast-lineage cell have been shown to be
important for other physiological systems. Osteoprogenitors can
support and modulate erythropoiesis [2] and mature osteoblasts
are responsible for many of the endocrine functions of bone,
including the regulation of energy expenditure [3–5] and male
fertility [6]. Furthermore, osteocytes play important roles in
mineral metabolism [7] and bone resorption [8,9]. Therefore, the
development of a more comprehensive understanding of the
molecular networks operative in osteoblast-lineage cells will have
important implications not only for osteoporosis, but many other
common complex diseases.
Genetic, molecular and biochemical approaches have been used
over the last decade to identify many of the key genes that are
required for osteoblast progenitor commitment, proliferation,
differentiation and apoptosis as well as mature osteoblast and
osteocyte activity [1]. An example of this has been the discovery
that the Wnt signaling pathway plays a central role in many
functional aspects of the osteoblast lineage [10]. However, these
investigations have been reductionist in nature and therefore have
not provided information on how key signaling genes interact in
complex cellular networks, which is critical to fully understand the
molecular mechanisms that underlie cellular processes and disease.
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In many cases, the insight gained regarding how genes interact in
networks goes well beyond what can be learned about a process
using only traditional approaches [11].
Systems genetics is an emerging approach that provides a
systems-level perspective of the role of genetic variation in cell
function and disease [12]. Systems genetics relies on the principles
and methods of systems biology, but focuses on determining how
naturally occurring genetic variation perturbs cellular phenotypes
[13]. The foundation of systems genetics is a suite of analytical
approaches that include genome-wide association, expression
quantitative trait locus (eQTL) discovery, causality modeling and
network analysis [14].
One of the most powerful systems genetics tools is network
analysis. Biological networks can be based on many different types
of interactions [15], such as genetic, protein-protein and
transcription factor binding. However, the most common
networks used in systems genetics research are based on co-
expression. In a systems genetics context, co-expression networks
are generated using global expression data collected across many
genetically unique individuals [16]. The patterns of gene
expression that result from each unique set of genetic perturba-
tions are used to quantify correlational relationships among genes
on a genome-wide scale. Co-expression networks typically display
two important behaviors, i) they are modular, with distinct
modules representing dense clusters of genes that are highly co-
expressed and ii) the co-expression modules are often enriched for
genes that share similar functions [17]. Because modules contain
functionally similar gene sets, they can be used to extract many
pieces of information about a system. For instance, a number of
studies have shown that summarized measures of module behavior
often correlate with complex processes or disease phenotypes [18–
20]. The identification of such modules provides a list of genes and
pathways that likely play a role in the process or disease. In
addition, genes within a module can be organized by connectivity.
Highly connected genes are called ‘‘hubs’’ and in a co-expression
network hub genes are those that are the most strongly correlated
with the largest number of other module genes [21]. Importantly,
a number of studies have found that connectivity correlates with
biologically relevant properties. For example, hubs in yeast
networks have been found to be more likely essential for growth
than non-hub genes [22] and connectivity was found to be
predictive of survival in a human brain co-expression module
associated with glioblastoma [23]. Recently, we demonstrated that
in a co-expression module associated with Bone Mineral Density
(BMD) in humans, hub genes were more likely to be genetically
associated with BMD than non-hub genes [24]. We have also
shown that hubs within a chrondrocyte co-expression network play
key roles in chrondrocyte differentiation [20].
In this study, we reconstructed a bone co-expression network
using Weighted Gene Co-expression Network Analysis (WGCNA)
and gene expression microarray profiles from femur samples
collected from 96 Hybrid Mouse Diversity Panel (HMDP) strains.
The resulting network was used to identify a core module of genes
(module 9; M9) specific to cells of the osteoblast-lineage. We then
demonstrated that the top two M9 hub genes were regulators of
osteoblast function and one was a regulator of BMD in vivo. In
addition, we showed that a local eQTL regulating the expression
of secreted frizzled-related protein 1 (Sfrp1), orchestrated the
transcriptional behavior of the M9. Notably, Sfrp1 is an antagonist
ofWnt signaling, which is a major pro-osteoblastic signal, and Sfrp1
transgenic and knockout mice display alterations in BMD and
osteoblast functions [25,26]. We further demonstrated the
physiologically relevant nature of the M9 by identifying a strong
non-linear relationship between the M9 and BMD in the HMDP
and that the M9 is enriched for genes implicated in the regulation
of human BMD through genome-wide association studies. In
summary, our results begin to clarify the composition and role of
cellular networks in the osteoblast cell lineage.
Results
Generation of a WGCNA network for bone in the HMDP
A genome-wide co-expression network for bone was constructed
by applying WGCNA to microarray gene expression profiles from
femur samples collected on 96 HMDP strains [27,28]. The
network was generated using all 45,719 expression probes
(representing 30,264 unique genes) present on the Illumina Mouse
WG6 microarrays. Of the total, 13,759 probes (10,968 unique
genes) were assigned to one of 21 co-expression modules (Table 1).
All other probes were not assigned to a module. Of the 21
modules, all but module 15 was enriched for genes belonging to
similar genome ontology (GO) or Kyoto Encyclopedia of Genes
and Genomes (KEGG) functional groupings (Table 1). Lists of
module assignments for all genes and all significant (FDR#0.05)
functional enrichments are provided in File S1 and File S2.
Module 9 is specific to the osteoblast-lineage
Given that bone is a heterogeneous tissue, we expected that a
subset of modules from the network would represent cell-type
specific networks. Therefore, we next set out to identify the co-
expression module that was the most relevant for the function of
osteoblast-lineage cells. We calculated two metrics, the Gene
Significance (GS) and Module Significance (MS) scores. The GS
for each network gene was defined as the absolute value of the
correlation between its expression and the eigengene summarizing
the expression of a group of nine (Col1a1, Col1a2, Akp2, Bglap1, Sp7,
Ibsp, Sost, Mmp13, Tnfrsf11b, Dmp1 and Phex) osteoblast/osteocyte
markers. These genes were selected prior to the network analysis
based on mining the literature for widely used markers of
osteoblasts and osteocytes. The MS was defined as the mean GS
for each module. In bone, the above marker genes are
preferentially (or exclusively) expressed in cells of the osteoblast-
lineage; therefore, a module with a high MS would be expected to
represent a sub-network of genes that function specifically in these
cells. Of the 21 modules, module 9 (M9) had the highest MS
Author Summary
The osteoblast-lineage consists of a range of cells from
osteogenic precursors that mature into bone-forming
osteoblasts to osteocytes that are entombed in bone.
Each cell in the lineage serves a number of distinct and
critical roles in the growth and maintenance of the
skeleton, as well as many extra-skeletal functions. Over
the last decade, many of the major regulatory pathways
governing the differentiation and activity of these cells
have been discovered. In contrast, little is known regarding
the composition or function of gene networks within the
lineage. The goal of this study was to increase our
understanding of how genes are organized into networks
in osteoblasts. Towards this goal, we used microarray gene
expression profiles from bone to identify a group of genes
that formed a network specific to the osteoblast-lineage.
We used the knowledge of this network to identify novel
genes that are important for regulating various aspects of
osteoblast function. These data improve our understand-
ing of the gene networks operative in cells of the
osteoblast-lineage.
Osteoblast Co-Expression Network
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(MS= 0.6260.02; P,0.002). The next highest MS scores were
observed for module 6 (MS=0.3260.02; P,0.002) and module
16 (MS=0.2760.01; P,0.002) (Figure 1A). All other modules
had MS scores at or below 0.20 (P.0.002).
We also expected that the most relevant module would contain
genes more highly expressed in osteoblasts than other bone cells.
To evaluate the expression patterns of all network genes we
utilized an independent set of microarray data which surveyed
global gene expression in primary osteoblasts (at 5, 14 and 21 days
of in vitro differentiation), primary osteoclasts, bone marrow and
whole bone [29]. M9 genes were over 4-fold (P,0.05) more highly
expressed in osteoblasts than whole bone or bone marrow and 2.8-
fold (P,0.05) more highly expressed in osteoblasts than osteoclasts
(Figure 1B–1D).
The M9 was significantly (FDR#0.05) enriched for 53 GO and
KEGG pathway terms (File S1). These included terms such as
‘‘extracellular matrix’’ (FDR=1.9610216), ‘‘collagen’’
(FDR=4.961027), ‘‘ossification’’ (FDR=3.061025), ‘‘bone de-
velopment’’ (FDR=8.661025), ‘‘skeletal system development’’
(FDR=4.961024), ‘‘Wnt receptor signaling pathway’’
(FDR=1.261023) and ‘‘regulation of bone mineralization’’
(FDR=3.761022), which are relevant to osteoblasts. Additionally,
we found that the M9 was enriched (Fisher’s exact test
P = 2.861028) in genes belonging to a list of 254 that were
members of 11 GO terms containing the term ‘‘osteoblast’’ (such
as ‘‘regulation of osteoblast differentiation’’ (GO:0045667) and
‘‘osteoblast proliferation’’ (GO:0033687)) or their perturbation in a
mouse model has been observed to affect osteoblast function.
Lastly, the M9 contained many known genes that, in bone, are
specific to or define the osteoblast-lineage. Examples include Akp2
(alkaline phosphatase), Bglap1 (bone gamma carboxyglutamate
protein; osteoclacin), Cd276 (CD276 molecule), Col1a1 (collagen,
type I, alpha 1), Col1a2 (collagen, type I, alpha 2), Lrp5 (low density
lipoprotein receptor-related protein 5), Mmp2 (matrix metallopep-
tidase 2), Pthr1 (parathyroid hormone receptor 1), Sp7 (Sp7
transcription factor 7), Tnfrsf11b (tumor necrosis factor receptor
superfamily, member 11b) and Wnt5a (wingless-related MMTV
integration site 5A). Together, these data indicate that M9
represents a core gene network specific to cells of osteoblast-
lineage.
M9 connectivity is correlated with GS
To characterize the M9 network we first determined if M9
topology was important for the function of osteoblast lineage cells.
We began by evaluating connectivity, a parameter of network
topology. Recently, a number of studies have shown that highly
connected ‘‘hub’’ genes tend to play critical roles in module
organization [19,24]. We defined connectivity (kme) for each gene
as the correlation between its expression and its module eigengene
[21]. Importantly, kme is a property inherent to each gene and
would not be expected to correlate with other individual gene
metrics (such as GS), unless the organization of the module was an
important property of the system. A strong positive correlation was
observed between M9 gene kme and GS (r = 0.89,
Table 1. Number of genes and most significant functional enrichment for each of the 21 bone network modules.
Module
No.
Probes
No. Unique
Genes Term Percenta Fold Enrichmentb FDR
1 2835 2504 GO:0007049,cell cycle 7.4 2.5 4.0610230
2 2551 2204 GO:0005739,mitochondrion 16.6 2.5 1.1610264
3 1752 1715 GO:0007608,sensory perception of smell 9.5 2.0 3.9610214
4 1107 981 GO:0044265,cellular macromolecule catabolic process 8.4 2.7 2.3610214
5 1106 1077 mmu03010:Ribosome 2.8 6.4 5.1610214
6 1017 910 GO:0005578,proteinaceous extracellular matrix 6.4 4.7 4.4610220
7 724 615 GO:0055114,oxidation reduction 16.6 4.7 7.2610238
8 452 425 GO:0000278,mitotic cell cycle 4.4 4.4 6.361025
9 400 354 GO:0031012,extracellular matrix 10.6 6.0 1.9610216
10 320 301 GO:0005739,mitochondrion 17.4 2.5 2.561028
11 279 278 GO:0031226,intrinsic to plasma membrane 6.0 2.7 3.761022
12 237 219 GO:0006814,sodium ion transport 9.4 14.9 7.7610216
13 227 199 GO:0050817,coagulation 7.1 23.4 3.4610212
14 174 171 GO:0005739,mitochondrion 32.9 4.5 3.3610222
15 98 96 NSc NS NS NS
16 95 94 GO:0015931,nucleobase, nucleoside, nucleotide and
nucleic acid transport
4.8 13.1 4.961022
17 88 76 mmu04142:Lysosome 14.7 17.7 1.561029
18 80 68 GO:0015629,actin cytoskeleton 14.1 12.5 4.861026
19 78 74 GO:0031981,nuclear lumen 17.3 4.1 9.761023
20 75 69 GO:0001944,vasculature development 16.4 11.5 3.661027
21 64 54 GO:0006955,immune response 36.2 14.4 3.0610214
aPercent = The percentage of module genes belonging to the listed GO or KEGG term.
bFold Enrichment = The ratio of the percentage of module genes with the listed GO or KEGG term relative to the percentage of genes belonging to that term across the
genome.
cNS =Not significant. There were no significant enrichments for module 15.
doi:10.1371/journal.pgen.1003150.t001
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P=7.76102141) (Figure 2), indicating that the more highly
connected an M9 gene, the more closely its expression resembles
that of a prototypical gene of the osteoblast lineage.
M9 hub genes, Maged1 and Pard6g, are novel regulators
of osteoblast activity
The immediate implication of this finding is that we could use
kme to determine if M9 hubs play a role in osteoblast function.
The top 10 M9 hub genes are listed in Table 2. We focused on the
two genes with the highest kme (Table 2), melanoma antigen,
family D, 1 (Maged1) and par-6 partitioning defective 6 homolog
gamma (C. elegans) (Pard6g). Maged1 is a transcriptional co-
activator that has been implicated in the regulation of myogenic
differentiation [30], sexual behavior [31], obesity [31] and the
transcriptional function of Dlx5 [32], a positive regulator of
osteoblast differentiation and bone mass [33,34]. Pard6g is a
homologue of the Par (partitioning defective) family of proteins
that are involved in the regulation of cell polarity. We
characterized the broad expression profiles of Maged1 and Pard6g
using microarray data from 96 mouse tissues and cell-types [29].
Maged1 and Pard6g were expressed in multiple samples including
primary calvarial osteoblasts (pcOBs) (Figure 3A). To confirm
these data, the expression of both genes was measured during
differentiation in an independent set of pcOBs. Maged1 and Pard6g
were differentially expressed (P = 0.03 for both genes) as a function
of osteoblast differentiation (Figure 3B). Maged1 expression
increased rapidly after the induction of differentiation, peaked at
day 6 and then decreased through day 20, possibly indicating a
more important role for Maged1 in early osteoblastogenesis. In
contrast, Pard6g expression increased more slowly, peaking at day
14 and then decreasing by day 20. The expression of Pard6g was
highly similar to established markers of osteoblast maturation
(Figure 3C–3F), especially Sp7, Akp2 and Ibsp.
We next determined the effects of Maged1 and Pard6g
knockdown on osteoblast proliferation and differentiation. Two
independent siRNAs (M1 and M2 for Maged1 and P1 and P2 for
Pard6g) were used to target each gene. At 48 hours post-
transfection in undifferentiated pcOBs, Maged1 transcript levels
were reduced to 18% and 14% of control in M1 and M2
transfected cells, respectively (P,0.05) (Figure 4A). At 96 hours
post-transfection in these cells, Maged1 knockdown was lower at
42% and 33% of control in M1 and M2 transfected cells,
Figure 1. Module 9 is a co-expression network specific to cells of the osteoblast-lineage. (A). Mean MS score for each of the 21 network
modules. (B) Mean module gene expression in osteoblasts relative to bone marrow. (C) Mean module gene expression in osteoblasts relative to
whole bone. (D) Mean module gene expression in osteoblasts relative to osteoclasts. In panels (B–D) expression is presented as the mean log2
expression for each gene in a module in osteoblasts minus log2 expression in the second sample. *Bonferroni adjusted P,0.002.
doi:10.1371/journal.pgen.1003150.g001
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respectively (P,0.05) (Figure 4A). Knockdown at the transcript
level resulted in similar reductions in MAGED1 protein levels
48 hours after transfection (Figure 4B). Maged1 knockdown
resulted in a 12% (P,0.10) and 31% (P,0.05) increase in
proliferation rate in M1 and M2 transfected undifferentiated
pcOBs, respectively (Figure 4C). In differentiating pcOBs (4 days),
M1 and M2 treatment led to 40% (P,0.10) and 118% (P,0.05)
increases in alkaline phosphatase activity (a marker of maturing
osteoblasts), respectively (Figure 4D). We also observed 69% and
74% increases in the transcript levels of the osteoblastic genes Sp7
and Akp2, respectively, in M2 treated cells (P,0.05) (Figure 4E).
No differences were observed for the other osteoblast markers
assayed (Figure 4E). Surprisingly, we observed a significant
(P,0.05) decrease in the ability of M1 and M2 transfected
osteoblasts to form mineralized nodules (a marker of mature
osteoblast function) at 14 days post-differentiation (Figure 4F–4H).
All the differences demonstrated a dose-dependent relationship
with the extent of Maged1 knockdown a the transcript level (the
effect of M2.M1), suggesting that the effects were specific for the
reduction in Maged1 levels.
At 48 hours post-transfection in undifferentiated pcOBs,
Pard6g transcript levels were reduced to 50% and 33% of
control in P1 and P2 transfected cells, respectively (P,0.05)
(Figure 4I). At 96 hours post-transfection, Pard6g knockdown
was lower at 74% and 63% of control in P1 and P2 transfected
cells, respectively (P,0.05) (Figure 4I). Knockdown at the
transcript level resulted in similar reductions in PARD6G
protein levels 48 hours after transfection (Figure 4J). Pard6g
knockdown resulted in a 12% (P = 0.10) and 62% (P,0.05)
decrease in proliferation rate in P1 and P2 transfected cells,
respectively (Figure 4K). In differentiating pcOBs (4 days), P1
and P2 treatment led to 66% and 71% decreases (P,0.05) in
alkaline phosphatase activity, respectively (Figure 4L). Addi-
tionally, 40% to 95% decreases (P,0.05) were seen in the
levels of the osteoblast markers Sp7, Runx2, Akp2, Col1a1,
Bglap1 and Ibsp (Figure 4M). Consistent with these observa-
tions, there was a significant (P,0.05) impairment in the
formation of mineralized nodules in P1 and P2 transfected cells
(Figure 4N–4P). All the differences demonstrated a dose-
dependent relationship with the extent of Pard6g knockdown at
the transcript level (the effect of P2.P1), suggesting that the
effects were specific for the reduction in Pard6g levels. These
data indicate that the M9 hub genes, Maged1 and Pard6g, are
novel regulators of osteoblast activity.
Figure 2. Connectivity is strongly correlated with GS in module 9. Plot showing the correlation (r = 0.89, P = 7.76102141) between
connectivity (kme) and GS among module 9 genes.
doi:10.1371/journal.pgen.1003150.g002
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Maged1-deficient mice have decreased BMD
To further assess the physiological function of Maged1, we
measured total body BMD in Maged1 deficient mice (Maged12). In
18 week-old male Maged12 mice, we observed significantly
(P,0.05) decreased BMD, relative to wild-type littermates
(Maged1+) (Figure 5A). This difference was primarily due to a
decrease in bone mineral content (BMC) and not skeletal size
(Figure 5B and 5C). Additionally, the difference was not a
reflection of alterations in lean body mass that would alter BMD
(Figure 5D).
Secreted frizzled-related protein 1 (Sfrp1) is a regulator of
the M9
We next sought to identify genetic loci responsible for the
coordinate expression of M9 genes. Two strategies were employed
for this analysis, the identification of expression QTL (eQTL)
hotspots and genome-wide association (GWA). Based on previous
studies [35], we anticipated that the identification of eQTL
hotspots would have more statistical power than genome-wide
association, but less mapping resolution. In contrast, genome-wide
association would be less powerful, but would allow us to more
precisely define the location of potential regulators. We choose a
priori to focus only on regions that were implicated by both
analyses, as these were the most likely to harbor true regulators.
We used the Efficient Mixed Model Algorithm (EMMA) [36] to
perform GWA for all network genes. The number of M9 genes
with eQTLs (2logP.4) in 5 Mbp bins across the genome was
counted and compared to the frequency of eQTL for all other
network genes. Several significant (Bonferroni corrected
P,9.461025) bins were identified, suggesting that the regulation
of M9 gene expression was polygenic. The most prominent
hotspots were located on Chrs. 8 (P= 6.1610232) and 3
(P = 5.1610219) (Figure 6A). We next used EMMA to directly
identify associations for the M9 eigengene. In both cases, the top
two hotspots/associations were concordant. The SNP
(rs33030926, P = 9.061026) that was the most strongly associated
with the M9 eigengene was located on Chr. 8 at 24.587852 Mbp.
(Figure 6B).
Both analyses provided strong evidence for the presence of a
regulator of the M9 on Chr. 8 at ,24.5 Mbp. It is possible that
such a regulator influences M9 gene expression through a
genetically regulated difference in its own expression and this
would be detectable as a local eQTL. To determine if this was the
case we identified all microarray probes mapping between 20 and
30 Mbp on Chr. 8. A total of 237 probes corresponding to 137
unique genes were located within the region. EMMA was used to
perform genome-wide association for each probe [36]. We then
selected the probe for each gene with the most significant local
eQTL. A total of 15 genes were found to be regulated by
significant (P#3.661024) local eQTL after correcting for multiple
comparisons (Table 3). We would expect that the causal genes
expression should be correlated with M9 gene expression. Thus,
we calculated the proportion of M9 genes whose expression was
correlated (r.|0.25|, nominal P,0.01) with the expression of
each candidate regulator. Most of the 15 candidates showed little
overlap (between 0 and 24%). However, the expression of Sfrp1
correlated with 88.8% of M9 genes at a threshold of r.|0.25|
(Table 3). Sfrp1 was correlated with all 400 M9 probes if the
threshold was reduced to r.|0.15|.
The most significant SNP regulating Sfrp1 expression was
rs33030926 (P= 5.0610211) located at 24.587852 Mbp. This SNP
was also the most significantly associated with the M9 eigengene
(P= 9.061026). Rs33030926 is located 27.7 Kbp downstream of
the 39 end of Sfrp1. We hypothesized that rs33030926 (or the
causal variant linked to rs33030926) regulates Sfrp1 expression,
which in turn influences the co-expression of M9 genes. To test
this hypothesis, we used the Network Edge Orienting (NEO)
causality modeling R package [37]. NEO is statistical approach
used to determine the relationship between genetic variation and
two traits. In our case we wanted to determine if rs33030926
Table 2. Ten most highly connected genes in the M9.
Gene Description Chr Mb kme Role in Osteoblasts Ref.
Maged1 melanoma antigen, family D, 1 X 91.8 0.93 Osteoblast proliferation and
differentiation and BMD in vivo
This study
Pard6g par-6 partitioning defective 6 homo
log gamma (C. elegans)
18 80.3 0.91 Osteoblast proliferation and
differentiation
This study
Kdelr3 KDEL (Lys-Asp-Glu-Leu) endoplasmic
reticulum protein retention receptor 3
15 79.4 0.91 Unknown NA
Kdelr3a KDEL (Lys-Asp-Glu-Leu) endoplasmic
reticulum protein retention receptor 3
15 79.4 0.90 Unknown NA
Rcn3 reticulocalbin 3, EF-hand calcium
binding domain
7 52.3 0.90 Downregulated in osteosarcoma [66]
C76566 expressed sequence C76566 8 107.8 0.89 a.k.a B3gnt9-ps; Unknown NA
Akp2 alkaline phosphatase 2, liver 4 137.3 0.89 Osteoblast marker; bone
mineralization
[67]
Col5a1 procollagen, type V, alpha 1 2 27.9 0.88 Low abundance fibrillar collagen i
n bone
[68]
Fkbp10 FK506 binding protein 10 11 100.3 0.88 Mutations lead to Osteogenesis
imperfecta, type VI
[69]
Tmem119 transmembrane protein 119 5 114.2 0.87 Osteoblast differentiation [70]
Gja1 gap junction membrane channel
protein alpha 1
10 56.1 0.87 Osteoblast differentiation [71]
aThe two different entries for Kdelr3 are from two separate microarray probes.
doi:10.1371/journal.pgen.1003150.t002
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affected Sfrp1 expression and if this in turn perturb the M9. NEO
was used to orient the relationships between rs33030926, each of
the 15 candidate regulators and the M9 eigengene by determining
if the data best fit a causal model (rs33030926Rcandidate
eQTLRM9 eigengene) or one of four competing models that
could be used to explain the data. The causal model was the best
fit for the Sfrp1 expression data with a causal score (LEO.nb.AtoB)
of 2.80 (Table 3). The LEO.nb.AtoB scores for the other 14
candidate eQTLs were negative (Table 3).
To further characterize the effect of Sfrp1 on the bone network
we stratified mice by rs33030926 genotype and calculated the
percent difference in transcript level in Sfrp1 and all M9 probes.
For Sfrp1, there was a 10.1% increase in transcript levels in strains
(N= 52) homozygous for the rs33030926 ‘‘C’’ allele, relative to
strains (N=44) homozygous for the rs33030926 ‘‘T’’ allele.
Similarly, its effect on M9 gene expression was subtle. The max
percent difference in expression between rs33030926 genotypes
for M9 probes was 27.2% with a mean of 7.4% (Table 4). We
conclude that Sfrp1 induces strong correlations between M9 genes
through the subtle coordinate regulation of their expression.
To add additional support for the causal role of Sfrp1, RNAi was
used to knockdown Sfrp1 expression in pcOBs. At four days post
differentiation, the expression of Sfrp1 was measured using qPCR
and network-wide gene expression using microarrays. In cells
transfected with a siRNA targeting Sfrp1, its expression was
reduced to 44% (P=0.001) of the level seen in cells transfected
with the scrambled control. Similar to the in vivo data in the
HMDP, the knockdown of Sfrp1 early in differentiation (four days
post-differentiation) exerted only minor perturbations in network
gene expression. Only a small number of the network genes were
classified as differentially expressed (FDR,0.05). However,
significant (P,0.002) mean differences in expression (difference
in expression between pcOBs transfected with Sfrp1 siRNA and
the scrambled siRNA) were observed for modules 9 and 21. In
addition, the M9 was the only module with a significant mean
percent difference in module gene expression in which there was a
significant correlation (r = 0.32, P= 4.861028) between the mean
percent difference in the HMDP and in response to Sfrp1
knockdown, indicating that the same M9 genes that were
perturbed in the HMDP were also altered due to Sfrp1 knockdown
Figure 3. Maged1 and Pard6g are expressed in osteoblasts. (A) Maged1 and Pard6g are expressed in multiple mouse tissues and cell-lines
including primary calvarial osteoblasts (outlined in red). The data are from a microarray experiment of tissues and cell lines (tissues and primary cell
lines from C57BL6/J mice) and are the mean6SEM of three biological replicates [29]. Images were downloaded and modified from BioGPS (http://
biogps.org/) [65]. The expression of (B) Maged and Pard6g, (C) Sp7, (D) Akp2, (E) Bglap and (F) Ibsp expression as a function of differentiation in primary
calvarial osteoblasts (P = 0.03 for Maged1 and Pard6g and P,0.001 for all other genes). The data represent mean6SEM (N=4 at each timepoint).
doi:10.1371/journal.pgen.1003150.g003
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(Table 4). Our in vitro experiments are consistent with Sfrp1
regulating the coordinate expression of the M9. Together, with the
systems genetics analysis from the HMDP, these data identify Sfrp1
as a regulator of the M9.
The M9 is associated with BMD in the HMDP
If M9 behavior in the HMDP is reflective of osteoblast/osteocyte
activity then we would expect that it would be associated with
changes in bone mass in the HMDP strains. We previously
measured BMD in all HMDP strains [27]. To assess its relationship
with BMD, we determined the correlation between the M9
eigengene and BMD. The M9 eigengene was not linearly correlated
(r =20.03; P= 0.71) with femoral BMD, however, as shown in
Figure 7 there was a U-shaped relationship between the two. Based
on this observation we fit a quadratic model (M9 eigengen-
e =BMD+BMD‘2) to the data (Figure 7). The quadratic model was
a highly significant fit (P= 1.161026). A shown in Figure 7, strains
with the highest M9 had either low or high BMD. As would be
expected based on the observation that rs33030926 regulates Sfrp1
and the M9 eigengene, all the strains with high expression of the M9
Figure 4. Maged1 and Pard6g are novel regulators of osteoblast proliferation and differentiation. (A) The siRNAs M1 and M2 significantly
reduced the levels of Maged1 in undifferentiated pcOBs relative to a scrambled control (SC) at 48 and 96 hours post-differentiation. (B) This resulted
in similarly decreased MAGED1 protein at 48 hours post-differentiation (L = protein ladder). (C) In undifferentiated pcOBs Maged1 knockdown
increased proliferation rate. (D) After four days of osteogenic differentiation Maged1 knockdown increased alkaline phosphatase activity (E) and the
expression of Sp7 and Akp2. In contrast, at 14-days post-differentiation Maged1 knockdown significantly decreased (F) mineralized nodule formation
as determined by (G) Alizarin Red staining and (H) quantification of nodule number. (I) The siRNAs P1 and P2 significantly reduced the levels of Pard6g
in undifferentiated pcOBs relative to a scrambled control (SC) at 48 and 96 hours post-differentiation. (J) This resulted in similarly decreased PARD6G
protein at 96 hours post-differentiation. (K) In undifferentiated pcOBs Pard6g knockdown increased proliferation rate. (L) After four days of
osteogenic differentiation Pard6g knockdown decreased alkaline phosphatase activity (M) and the expression of Sp7, Runx2, Akp2, Col1a1, Bglap1 and
Ibsp. (N) At 14-days after differentiation Pard6g knockdown decreased mineralized nodule formation as determined by (O) Alizarin Red staining and
(P) quantification of nodule number. In all panels *P,0.05 and #P,0.10. The data represent mean6SEM (N= 4–6 independent experiment, except
for Westerns (N = 2)).
doi:10.1371/journal.pgen.1003150.g004
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eigengene and the lowest and highest BMDwere ‘TT’ homozygotes
(Figure 7). Similar patterns were observed for total body and spinal
BMD (data not shown). Importantly, these data provide additional
evidence of the biological relevance of the M9. It also suggests that
the M9 reflects the complex, and often contradictory, role of
osteoblast-lineage cells in bone homeostasis.
M9 is enriched for genes implicated in human BMD GWA
studies
To evaluate the potential relevance of the M9 to BMD in
humans we determined if it contained genes that have been
implicated in the regulation of BMD through human GWA
studies. We used information from the largest GWA analysis for
BMD performed to date. This study meta-analyzed data from
17 BMD GWA studies (N =,32 K in the discovery phase and
N=,50 K in the replication phase) [38]. In this meta-analysis,
a total of 64 independent SNPs reached genome-wide signifi-
cance implicating 56 regions and 61 unique genes (these genes
were the closest to the most significant independent GWA
SNPs). We were able to identify a mouse homolog for 57 of the
61 genes (93%) and 39 were located within one of the 21
network modules (Table 5). Of these, five (8.7% of the total)
(Lrp5, Tnfrsf11b, Wnt4, Gpr177 and Sp7) were members of the
M9. The probability of identifying five M9 genes among 57
randomly chosen genes from the network was P = 5.061024.
After a Bonferroni correction for the 21 modules, the M9 was
the only module to demonstrate this enrichment. These data
indicate the M9 is enriched for genes that have been implicated
in the regulation of BMD in humans.
Discussion
In this study, we generated a co-expression network for bone
that consisted of 21 ‘‘modules’’, each of which contained genes
that shared similar expression patterns and were enriched for
functionally similar genes. We then focused on one module, the
M9, which was predicted to be specific for cells of the osteoblast-
lineage. We demonstrated that the perturbation of M9 hub genes
altered osteoblast proliferation and differentiation and for one hub,
Figure 5. BMD is decreased in Maged1-deificient mice. (A) BMD and (B) BMC is decreased in Maged12 mice relative to wild-type littermates
(Maged1+). There is no difference in (C) bone area or (D) lean mass between genotypes. *P,0.05.
doi:10.1371/journal.pgen.1003150.g005
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Maged1, BMD in vivo. Additionally, we discovered that an Sfrp1
local eQTL was the key driver of M9 gene expression, that the M9
was associated with BMD in the HMDP and was enriched for the
homologs of genes implicated in the regulation of BMD through
human GWA studies.
Traditional genetic and molecular approaches are powerful
tools for dissecting cellular function, however, reductionist
techniques may not be able to capture the overall organization
of cellular interactions. Systems genetics is an approach that can
provide an unbiased and more comprehensive view of not only the
genes involved in cell function, but also key gene-gene interactions.
By using the hundreds of thousands of genetic perturbations that
exist in the HMDP to identify correlational patterns between genes
on a genome-wide scale we were able to discover a core group of
354 genes that are highly co-expressed and function together in a
network. We believe that this network acts to propagate or
modulate major osteoblastic stimuli, such as Wnt signaling.
Importantly, the M9 represents a wealth of information that can
be mined in future experiments to increase our understanding of
the genes and interactions that are critical for proper osteoblast-
lineage function.
The use of network analysis provided a number of unique
advantages. First, WGCNA gave us the opportunity to group
genes into modules based on their in vivo patterns of expression in
whole bone and then determine which module was the most
relevant to cells of the osteoblast-lineage. Second, in a traditional
differential expression analysis across strains, only a small
percentage of M9 genes would have been identified as differen-
tially expressed and thus, potentially important in bone. Third, the
discovery that M9 connectivity was highly correlated with GS
could have only been made via network analysis. Lastly,
integrating network analysis and GWA identified Sfrp1 as a
regulator of the M9. Although Sfrp1 is known to play an important
role in the osteoblast lineage, our results have identified an entire
network of genes that are novel downstream targets of Sfrp1.
A number of recent works have identified ‘‘module quantitative
trait loci (mQTL)’’ (as examples [35,39,40]). Here, we identified
Sfrp1 as the gene and its local eQTL as the mechanism underlying
the mQTL regulating the M9 eigengene. This represents one of
the first successful attempts at identifying the molecular basis of an
mQTL. This was possible due to the ability to perform high-
resolution genome-wide association in the HMDP and the tools of
Figure 6. EQTL hotspot identification and genome-wide association identifies a regulator of M9 on Chromosome 8. (A) Genome-wide
scan for regions associated with the expression of a large number of M9 genes. The dashed line is a genome-wide significance threshold of
2log10(P = 9.461025). (B) EMMA genome-wide association scan for the M9 eigengene.
doi:10.1371/journal.pgen.1003150.g006
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systems genetics. This study highlights the advantages of disen-
tangling the genetics of co-expression module regulation using a
high-resolution genetic reference population such as the HMDP.
We observed that the M9 eigengene was inversely correlated
with BMD in low bone mass mice and positively correlated with
BMD in high bone mass mice. This nonlinear association is likely
due the complex roles of osteoblast-lineage cells in bone [1].
Osteoblasts directly control bone formation and secrete Osteo-
protegerin, a strong inhibitor of bone-resorbing osteoclasts [1].
Moreover, pre-osteoblasts and recently osteocytes, have been
shown to secrete RANKL, which promotes osteoclastogenesis and
bone resorption [8,9,41]. Therefore, M9 ‘‘activity’’ likely repre-
sents a balance between osteoblast-mediated bone formation and
osteoblast/osteocyte-directed bone resorption. It is possible that
the differential effect of high M9 activity in the HMDP is due to
differences cell composition (e.g. differences in the relative
numbers of osteoprogenitors, mature osteoblasts and osteocytes)
or other factors that are determined by genetic background.
Consistent with the role of genetic background, many of the low
BMD HMDP strains with high M9 eigengene expression belonged
to the AXB recombinant inbred set. More detailed phenotyping of
strains with high M9 expression and low or high BMD will be
needed to clarify the difference. At any rate, the association
between M9 and BMD indicates that it reflects physiologically
relevant differences in the activities of osteoblast-lineage cells.
We identified a strong correlation betweenM9 connectivity (kme)
and GS. This finding is important since it suggests that not only are
M9 genes important, but the topology of the M9 network is also
important for the function of osteoblast-lineage cells. This finding
allowed us to use kme information to prioritize genes for validation.
Because the most highly connected genes were the most correlated
with GS, we choose the top two hubs for further investigation. Many
of the top ten hubs are known to function in osteoblasts (Table 2);
however, the top two, Maged1 and Pard6g, have not been shown to
directly participate in osteoblast proliferation, differentiation or
mineralization. Using RNA interference we demonstrated that both
genes play a role in osteoblast activity.
The siRNA knockdown of Maged1 increased the proliferation of
primary calvarial osteoblasts. It also increased the early expression
of alkaline phosphatase, a marker of maturing osteoblasts.
Surprisingly though, we found that it decreased mineralized nodule
formation. Maged1 is a transcriptional co-activator involved in a
wide-array of cellular processes such as the regulation of myogenic
differentiation, circadian rhythms, sexual behavior and obesity, to
name a few [30,31,42]. Maged1 has been shown to bind to the
homeodomain protein DLX5 and is required for its transcriptional
function [32]. Consistent with Maged1 affecting osteoblast function
through DLX5, mineralized nodule formation in osteoblasts from
Dlx52/2 knockout mice is also lower. However, proliferation in
Dlx52/2 osteoblasts is also decreased in contrast to the increase in
proliferation we observed whenMaged1 is knocked-down. The effect
ofMaged1 on proliferation in osteoblasts, however, is consistent with
the observations that it inhibits proliferation in other cell-types
[43,44]. This suggests the Maged1 may have effects on osteoblast
function independent of DLX5 activity. The increase in alkaline
phosphatase and Sp7 expression at 4 days post-differentiation (both
markers of osteoblast differentiation) is hard to reconcile with the
decreased mineralized nodule formation at 14 days post-differen-
tiation. It is worth noting that Sp7 and Akp2 were the only osteoblast
markers that were increased, which suggests that Maged1 knock-
down may selectively result in increased Sp7 and Akp2 expression
without inducing the complete differentiation cascade. However, as
suggested above it could also reflect diverse roles for Maged1 in the
osteoblast. An alternative explanation is that the conflicting early
increase and late decrease in osteoblast differentiation is a result of
the transient nature of Maged1 knockdown with siRNA. Most
importantly, however, we demonstrate that Maged1 deficiency in
vivo results in decreased BMD. This is consistent with decreased
Table 3. Sfrp1 is predicted to be a regulator of the M9.
Gene Chr Mbp eSNP P SNPsa Overlap (%)b ME rc LEO.NB.AtoBd
Nek3 8 23.230919 1.2E-16 0 25.8 20.27 23.21
Defcr15 8 23.230919 3.4E-04 0 0.3 0.06 24.75
Defcr20 8 23.381591 2.3E-04 1 2.3 0.05 24.72
AI316807 8 23.643226 1.9E-08 0 6.8 20.14 24.28
Mrps31 8 23.993464 9.9E-09 4 23.3 20.18 24.04
Ank1 8 24.129746 2.5E-08 0 18.8 20.23 23.48
Gins4 8 24.316596 9.9E-07 0 17.0 20.18 24.78
Golga7 8 24.4321 5.9E-12 1 12.0 0.21 23.72
Sfrp1 8 24.587852 5.0E-11 0 88.8 0.53 2.8
Whsc1l1 8 27.001571 1.6E-05 0 2.3 0.02 24.54
Hgsnat 8 27.348861 1.7E-12 2 0.8 20.07 24.43
Erlin2 8 28.078367 2.7E-04 2 4.5 0.12 24.85
Prosc 8 28.171596 1.4E-16 0 11.8 20.09 24.53
Eif4ebp1 8 28.371247 1.9E-14 0 9.5 20.14 24.48
5430430B14Rik 8 28.377596 1.9E-06 3 15.0 20.24 23.76
aSNPs = The number of SNPs (from dbSNP128) that overlap probes for each gene that may be giving rise to falsely significant eSNP. Note that the probe representing
Sfrp1 does not overlap with a known SNP.
bOverlap = The percentage of module 9 genes correlated with Sfrp1 at |r.0.25|.
cME r = Pearson correlation between each candidates expression and the module 9 eigengene.
dLEO.NB.AtoB = The log2 ratio of the causal model fit over the fit of all other possible models (see Methods). A positive causal score$1 indicates that the eSNP is
predicted to be upstream and causal for the module 9 eigengene.
doi:10.1371/journal.pgen.1003150.t003
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mineralized nodule formation in vitro. It is also consistent with
Maged1 mediating its effects on osteoblast function through DLX5,
as Dlx5 deficient mice also have decreased bone mass [33]. Further
work is needed to define the precise role ofMaged1 in osteoblasts and
how this translates into lower bone mass.
The Par6 (partition defective) family of proteins was first
identified in C. elegans and Drosophila as proteins required to
establish cell polarity [45]. There are three homologues of Par6 in
mammals, PARD6A, 6B and 6G [46]. The siRNA knockdown of
Pard6g decreased both osteoblast proliferation and differentiation.
It is possible that these effects of Pard6g are due strictly to the fact
that cell polarity is an essential cellular process and are not
necessarily reflective of Pard6g function in osteoblasts. However,
we feel this is unlikely given its membership in the M9 and the fact
that its expression is high in osteoblasts and its expression differs as
a function of osteoblast differentiation. In addition, Par6 has
recently been shown to be involved in skeletogenesis and
biomineralization in the sea urchin [47]. Although more work is
needed it is tempting to speculate that Pard6g is involved in Wnt
signaling. Non-canonical Wnt signaling is a major regulator of cell
polarity and the M9 contains non-canonical Wnts such as Wnt4
(also a gene associated with BMD in humans) [48].
The Wnt signaling pathway is a major pro-osteoblast stimulus
[10]. In osteoblasts, Wnts bind frizzled (Fzd) receptors and their co-
receptors (LRP5 and LRP6) and induce the stabilization and
translocation of ß-catenin to the nucleus [10]. Sfrp1 antagonizes
Wnt signaling by interfering with the interaction between Wnts and
Fzd receptors [49]. Sfrp1 knockout mice are resistant to age-related
decreases in trabecular bone mass and display reduced osteoblast/
osteocyte apoptosis and increased osteoblast proliferation and
differentiation [50]. Conversely, Sfrp1 transgenic mice have
decreased trabecular and cortical BMD and decreased osteoblast
proliferation and differentiation [25]. Using genome-wide associ-
ation we identified Sfrp1 as a regulator of M9. Based on its known
role in cells of the osteoblast-lineage, its discovery as a major
regulator of the M9 is consistent with M9 representing a core
network operative in osteoblasts/osteocytes.
There has been interest in developing therapeutics targeting
Wnt signaling in general and Sfrp1 specifically. In fact, Bodine et al.
demonstrated that piperidinyl diphenylsulfone sulfonamide could
bind and inhibit the activity of SFRP1 [51,52]. However, there is
concern that Sfrp1 is a poor drug target based on its broad tissue
expression and the link between Wnt signaling and various cancers
[26]. Given that Sfrp1 regulates M9 gene expression it is likely that
many M9 genes are downstream targets of Sfrp1 and more
generally Wnt signaling. This notion is supported by the
observation that the perturbation of Maged1 and Pard6g expression
resulted in similar effects on pcOBs as did Sfrp1 alteration [25].
Targeting M9 genes could promote increased bone formation in a
more bone-specific manner.
Recent studies have demonstrated that co-expression modules
can be conserved across species; therefore, it is of significant
interest to know if the human homologs of M9 genes function in a
similar network. We will directly investigate this in future studies,
Table 4. Sfrp1 knockdown in primary calvarial osteoblasts preferentially alters the expression of module 9 genes.
Module
ME Chr. 8
SNP ra P
HMDP
Diff (%)b P
SiRNA
Diff (%)c P
HMDP SiRNA
Diff rd P
1 20.21 4.561022 3.5 ,161024 5.1 0.99 0.21 1.461024
2 0.08 0.45 2.4 0.88 5.5 0.52 0.02 0.41
3 20.09 0.41 0.6 1.0 3.8 1.0 0.14 6.061022
4 20.28 5.961023 2.8 ,1.061024 5.6 0.39 0.07 0.45
5 20.03 0.78 1.1 1.0 5.5 0.50 0.24 1.261025
6 0.32 1.461023 4.6 ,1.061024 6.6 3.461022 0.16 7.861025
7 20.07 0.51 1.6 1.0 4.1 1.0 0.10 0.19
8 20.02 0.83 1.3 1.0 4.7 0.93 0.01 0.89
9 0.44 9.261026 7.4 ,1.061024 8.1 1.161023 0.32 4.861028
10 20.14 0.17 1.8 1.0 6.4 0.11 0.03 0.80
11 0.12 0.25 0.6 1.0 4.8 0.82 0.09 0.30
12 0.13 0.21 1.6 1.0 3.9 1.0 0.10 0.20
13 20.07 0.53 1.5 1.0 4.5 0.96 0.33 3.061022
14 0.01 0.91 1.2 1.0 5.1 0.63 0.03 0.81
15 20.04 0.68 0.8 1.0 3.8 0.91 20.35 0.29
16 20.25 1.361022 2.7 0.24 5.5 0.40 20.21 0.79
17 0.17 9.861022 3.6 2.761023 5.8 0.29 0.11 0.39
18 0.11 0.27 3.8 1.061023 6.6 0.11 20.10 0.53
19 20.22 3.361022 3.2 3.861022 6.2 0.20 0.01 1.0
20 0.17 9.561022 2.7 0.29 6.2 0.15 0.23 0.20
21 0.08 0.44 1.5 1.0 76.1 ,1.061024 0.02 0.93
aME Chr.8 SNP r = correlation between module eigengene and the chr. 8 SNP (rs33030926) associated with module 9 and Sfrp1 expression.
bHMDP Diff =mean % difference in module gene expression stratified by rs33030926 genotype ((genotype ‘TT’-genotype ‘CC’)/genotype ‘TT’ *100).
cSiRNA Diff =mean % difference in module gene expression in as a function of Sfrp1 siRNA knockdown ((Sfrp1 siRNA-Scrambled Control)/Sfrp1 siRNA*100).
dHMDP SiRNA= Pearson correlation between HMDP Diff and SiRNA Diff within each module.
All P-values in bold are significant at P#0.002 (Bonferroni corrected for the number of modules tested).
doi:10.1371/journal.pgen.1003150.t004
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however, the fact that conserved pathways (primarily Wnt
signaling) are represented in the M9 suggests that the majority
of M9 genes will also play a role in the function of osteoblast-
lineage cells in humans. Additionally, the fact that nearly 10% of
genes implicated in the most comprehensive BMD GWA meta-
analysis performed to date are members of the M9 further support
the notion that the M9 is relevant to the regulation of human
BMD. It is worth noting that 4 of the 5 M9 human BMD genes are
involved directly in Wnt signaling, which again suggests that this
signaling pathway is a major component of the M9.
Our approach is not without limitations. One possible
limitation, which also may have been an advantage, was the
generation of expression data from bone tissue. An alternative
approach would have been to profile isolated cell populations. This
may have been more informative since it is clear that the different
cells in the osteoblast-lineage perform distinct and often contra-
dictory functions. On the other hand, the profiling of bone cells in
their native complex cellular milieu may have resulted in
expression profiles that were more representative of their true in
vivo state. At any rate, we do believe that it will be informative in
future studies to repeat this analysis using isolated cell populations
as this may remove some of the noise associated with averaging
expression across multiple cell-types. A second limitation was our
use of siRNA in primary calvarial osteoblasts to validate the role of
Sfrp1, Maged1 and Pard6g. In terms of Sfrp1, we perturbed its
expression in vitro at one time point in osteoblasts isolated from
neonatal mice. Although this system allowed us to test the
hypothesis that Sfrp1 preferentially modulated the expression of M9
genes, it did not fully recapitulate the effects of Sfrp1 expression
differences in the HMDP. It is known that Sfrp1 has many effects
on osteoprogenitors, mature osteoblasts and osteocytes [50]. Thus,
it would have been more ideal to test the effect of Sfrp1
perturbation in vivo, which will be the focus of future investigations.
The same is true for Maged1 and Pard6g. Although we clearly
demonstrate their involvement in osteoblast proliferation and
differentiation, it is possible that we missed many aspects of their
function by focusing on just two stages in the complicated life-cycle
of an osteoblast-lineage cell. This is especially true in the case of
Maged1 were we observed that its reduction increased certain
aspects of early osteoblast differentiation, but later decreased
mineralized nodule formation.
In summary, we have used a systems genetics approach
consisting of co-expression network analysis, eQTL analysis,
genome-wide association and causality modeling in a powerful
mouse genetic reference population to identify a module (M9) of
co-expressed genes that play an important role in the function of
osteoblast-lineage cells. These data improve our understanding of
the gene networks important for osteoblast function and demon-
strates the ability of systems genetics to unravel gene networks
involved in complex cellular processes.
Figure 7. Nonlinear association between the M9 eigengene and BMD. Plot showing the relationship between the M9 eigengene and femur
BMD in the HMDP. A quadratic model (M9 eigengene= BMD+BMD‘2) significantly (P = 1.161026) fit the data. The quadratic line is shown in green.
Each diamond represents a strain and those in red are homozygous ‘TT’ and those in black are homozygous ‘CC’ at rs3303926 SNP that regulates
Sfrp1 expression and the M9 eigengene.
doi:10.1371/journal.pgen.1003150.g007
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Materials and Methods
Ethics statement
The Institutional Care and Use Committee (IACUC) at the
University of California, Los Angeles approved the animal
protocol for the HMDP. The animal protocol for the isolation
of primary calvarial osteoblasts was approved by the University of
Virginia IACUC. The manipulations of Maged1-deficient mice has
been approved by the local ethics committee of the University of
Namur and follow the European legislation.
Bone expression profiles and BMD in the Hybrid Mouse
Diversity Panel
Data from Hybrid Mouse Diversity Panel (HMDP) were
generated from 16-week old male mice from 96 inbred strains.
More details regarding the population can be found in [27,28].
RNA isolation and Illumina microarray processing for bone tissue
samples from the HMDP are described in [26]. The expression
data are available from the NCBI Gene Expression Omnibus
(GEO) database (GSE27483). The quantification of femoral,
spinal and total BMD in the HMDP has been described in [27].
Analyzing BMD in Maged1-deficient mice
The Maged1-deficient mice and control littermates used in this
study have already been described [53]. Experiments were done
with male mice aged 18 weeks backcrossed for .10 generations in
the C57Bl/6J genetic background. Body composition and BMD
was measured using a dual-energy X-ray absorptiometry (DEXA)
scanner (Lunar PIXImus2; GEHealthcare). All scans were analyzed
using the PIXImus2 software (version 2.10). For the calculation of
total body BMD the skull was excluded from the analysis.
Weighted gene co-expression network analysis
Network analysis was performed using the WGCNA R package
[54]. All 45,759 array probes were used to construct the bone
network. We did not collapse multiple probes per genes down to a
single probe representing each gene since many of the seemingly
redundant probes actually recognize alternatively spliced isoforms.
We also did not have to worry that the inclusion of probes that were
not expressed would add noise, since the vast majority of such probes
would not be expected to exhibit biologically meaningful correlations
with a large number of other transcripts. The approach also allowed
for the inclusion of probes that are truly expressed, but at a level that
may not have exceeded a particular ‘‘expressed/not expressed’’
threshold. To generate the co-expression network, we first calculated
Pearson correlation coefficients for all gene-gene comparisons across
all microarray samples. The matrix of correlations was then
converted to an adjacency matrix of connection strengths. The
adjacencies were defined as aij~Dcor xi,xj
 
Db where xi and xj are
the ith and jth gene expression traits. The power b was selected using
the scale-free topology criterion previously outlined by Zhang and
Horvath [55]. In this study a b=8 was used.Modules were defined as
Table 5. Module 9 is enriched in homologs of human genes implicated in the regulation of BMD through genome-wide
association studies.
Module No. Unique Module Genesa No. BMD GWAS homologsb Enrichment P-valuec Genes
1 2504 4 0.70 Anapc1, Sox6, Mpp7, Arhgap1
2 2204 5 0.39 Mef2c, Mapt, Cdkal1, Cyld,
AW548124
3 1715 4 0.40 Sox9, Rps6ka5, AI597468, Smg6
4 981 0 1.0
5 1077 3 0.34 Ctnnb1, Jag1, Lin7c
6 910 7 0.02 Hoxc6, Kcnma1, Spnb2, Sost, Wnt16,
Mepe, A430107O13Rik
7 615 4 0.13 Mbl2, Slc25a13, Insig2, Cpn1
8 425 1 0.55 Mark3
9 354 5 561024 Lrp5, Tnfrsf11b, Wnt4, Gpr177, Sp7
10 301 1 0.43 Klhdc5
11 278 1 0.40 BC030867
12 219 0 1.0
13 199 0 1.0
14 171 1 0.27 Abcf2
15 96 0 1.0
16 94 0 1.0
17 76 1 0.14 Tnfrsf11a
18 68 1 0.12 Rspo3
19 74 0 1.0
20 69 1 0.12 Dhh
21 54 0 1.0
aNumber of unique genes in each module.
bNumber of human homologs implicated in the regulation of BMD in [38].
cP-value for the enrichment of human BMD genes.
doi:10.1371/journal.pgen.1003150.t005
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sets of genes with high topological overlap [21]. The topological
overlap measure (TOM) between the ith and jth gene expression
traits was taken as TOM~
X
u=i,j
aiuaujzaij
min k:totali, k:totalj
 
z1{aij
, where
P
u=i,j
aiuauj denotes the number of nodes to which both i and j are
connected, and u indexes the nodes of the network. A TOM-based
dissimilarity measure 1{TOMð Þ was used for hierarchical
clustering. Gene modules corresponded to the branches of the
resulting dendrogram and were precisely defined using the
‘‘Dynamic Hybrid’’ branch cutting algorithm [56]. A principal
component analysis was used to generate a vector of values (first
principal component) that summarized or were the most represen-
tative of each modules expression. Intramodular connectivity (kme)
was defined as the correlation between a gene’s expression and its
module eigengene. Highly similar modules were identified by
clustering and merged together. Network depictions were con-
structed using Cytoscape [57].
Module characterization
The gene content of each module was characterized using the
DAVID gene enrichment analysis tool [58,59]. Gene Significance
(GS) for each network gene was defined as the absolute value of its
correlation with the eigengene of a set of nine osteoblast/osteocyte
marker genes identified from the literature. Module Significance (MS)
was calculated as the mean GS for each module. Significance of the
MS was determined for each module by randomly selecting x GS
scores from the set of 13,579 network GS scores; where x is equal to
the number of genes in that module. The mean for each set was then
calculated and this was repeated 10,000 times. The true MS score
was then compared to the distribution of random mean GS scores
and P-values were calculated by counting the number of random
mean GS scores that were greater than the true MS score divided by
10,000. AnMS score with a P,0.002 (Bonferroni adjusted for the 21
modules tested) was deemed significant. To determine the expression
patterns of network genes in bone and bone cells microarray data on
primary osteoclasts, primary osteoblasts, whole bone and bone
marrow were downloaded from GEO (GSE11339 and GSE10246).
The samples were derived from C57BL6/J mice in triplicate. The
osteoblast samples were comprised of three different time-points (5,
14 and 21 days of differentiation) assayed in triplicate. For each
module the log2 fold expression of its genes in osteoblasts (highest of
the three time-points) were compared to the other samples. Statistical
significance of the increase in expression in osteoblasts was
determined as described above for GS and MS.
EMMA and eQTL hotspot detection
EMMA and its application to HMDP data has been described
in [27,28,36,60]. EQTL hotspots for the M9 were identified by
performing genome-wide association for the expression of all
13,759 network probes using EMMA. SNPs were clustered into
531, 5-Mbp bins across the genome and for each network probe,
the minimum association p-value was recorded for each bin and
the number of probes with p-values that exceeded 2logP$4 were
counted. Enrichment P-values were then assigned to each bin
using a Fisher’s exact test to compare the frequency of significant
associations for M9 probes relative to all other network probes.
Bins with P,0.05/531= 9.461025 were deemed significant.
Causality modeling using network edge orienting (NEO)
Causality modeling was performed as described in [61,62].
Briefly, NEO is an R function designed to orient the relationships
between genetic markers, gene expression traits and clinical traits
[37]. NEO utilizes the fact that all cellular information begins with
DNA and therefore, the many possible relationships that can exist
between DNA variation, gene expression and clinical traits can be
distilled to three. The three relationships (or models) are: 1) causal
– flow of information goes from DNA to gene to BMD (gene’s
expression is causing the change in the trait); 2) reactive – flow of
information goes from DNA to BMD to gene (gene’s expression is
reacting to the change in the trait) and 3) independent – DNA
variation affects both traits independently. NEO uses structural
equation modeling to estimate the probabilities for each of the
three relationships. The log10 ratio of the causal model probability
relative to the next best model probability (of the two remaining) is
then calculated. This ratio (referred to as the LEO next best or
LEO.NB score) quantifies the relative likelihood that a gene’s
expression is causal for a trait such as BMD. Simulation studies
have demonstrated that single marker LEO.NB scores above 1.0
are highly suggestive of causal relationships [37].
Analysis of human GWA data
The mouse homologs for human genes nearest the most
significant SNP for all genome-wide significant associations
identified in [38] were identified. A clear homolog was identified
for 57 associations. The module membership for each of the 57
genes was then determined. Enrichment p-values for each module
were calucated by randomly selecting6genes, where x is the
number of genes in a given module, out of the 30,264 unique
genes used to generate the network. This was repeated 10,000
times. The number of randomly selected genes that overlapped the
GWA set in each random selection was then recorded. The
enrichment P-value was calculated as the number of times (out of
10,000) the overlap equaled or exceeded the actual number
observed for each module. An enrichment P-value corrected for
the 21 modules (0.05/21= 0.0023) was deemed significant.
Isolation of pcOBs
Three to nine day old neonates from C57BL/6J breeding pairs
(obtained from Jackson Laboratory, Bar Harbor, ME) were
euthanized by CO2 inhalation followed by decapitation. The
heads were sprayed with 70% ethanol and placed in sterile cold
DPBS (Gibco). Using sterile instruments, the skin was removed
from the skull, calvariae were removed and placed into sterile cold
DPBS (Gibco). Harvested calvariae were then placed in sterile
digestion solution (0.05% Trypsin-EDTA, 1.5 U/ml Collagenase
P, MEM Alpha) and incubated at 37uC, with 120 rpm shaking for
15 minutes. Four digests were performed, the first being discarded.
For the remaining three digests an equal volume of sterile plating
media (DMEM, 10% heat-inactivated FBS, 100 U/ml penicillin,
100 ug/ml streptomycin) was added to each immediately follow-
ing its collection and stored on ice. The fractions were combined,
filtered through a 100 uM sterile vacuum filtration tube and
counted.
Differentiation of pcOBs
Cells isolated from 4–6 independent groups of 3–9 day old
neonates were plated into 6 well plates at 300,000 cells/2 ml
sterile plating media (DMEM, 10% heat-inactivated FBS,
100 U/ml penicillin, 100 ug/ml streptomycin) per well. After
24 hours, confluent cells (Day 0) were washed 16 with DPBS
(Gibco) and placed in sterile differentiation media (DMEM, 10%
FBS, 100 U/ml penicillin, 100 ug/ml streptomycin, 0.1 M
ascorbic acid, 1 M B-glycerophosphate). Every 48 hours there-
after cells were washed one time with DPBS (Gibco) and
differentiation media replaced.
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siRNA transfection of pcOBs
PcOBs were plated at 150,000 cells/2 ml plating media per
well. Transfections were performed using Lipofectamine 2000
Reagent (Invitrogen) according to manufacturer’s directions. A
total of three Stealth Select RNAi siRNAs (Invitrogen) per gene
were first tested using three different concentrations (0.2 nM,
2.0 nM or 10 nM). Knockdown of the target gene was tested at
48 hours using qPCR in undifferentiated pcOBs (see below). All
siRNAs demonstrated the most effective knockdown at 10 nM. The
two most effective siRNAs for each gene were used for all
downstream experiments with the exception of Sfrp1 and only one
of the three provided more than 50% knockdown. The sense strand
of the duplex siRNA sequences were as follows: Sfrp1 - MSS277026;
CCGAGAUGCUCAAAUGUGACAAGUU; Maged1 – MSS294
723; GCAAGGUUAAUAACUUGAAUGUGGA and MSS2351
63; UCAGAACGUGGAGUCCCGGACUAUA; Pard6g MSS234
948; GCAACGGCAGCAUCCACAGAUUUCU and MSS234
949; CAUAAGUCUCAGACCCUACGCUUCU. The Stealth
RNAi Negative Control Duplex (Invitrogen) was used as a
scrambled control. As a control, we also demonstrate in File S3
that knockdown of Kdelr3 (a gene expressed in primary calvarial
osteoblasts) has no effect on mineralized nodule formation,
providing additional support that the effects of target gene siRNA
are due specific to the knockdown ofMaged1 and Pard6g (File S3). At
24 hours post-transfection, cells were trypsinized (0.25% Trypsin-
EDTA) and re-plated in a 12 well plate. The following day cells
reached 100% confluency (Day 0) and were washed 26with sterile
DPBS (Gibco) and placed in sterile differentiation media (DMEM,
10% FBS, 100 U/ml penicillin, 100 ug/ml streptomycin, 0.1 M
ascorbic acid, 1 M B-glycerophosphate). Every 48 hours thereafter
cells were washed 16with DPBS (Gibco) and differentiation media
replaced.
Protein isolation and Western blots
Protein was extracted from pcOBs in 10% NP40 detergent
containing protease inhibitors (Thermo Scientific). The extracts
were separated on 12% NativePAGETM Novex Bis-Tris Gels (Life
Technologies) and transferred to PVDF membranes. Antibodies
were obtained from Santa Cruz Biotechnology (PARD6G) and
Milipore (MAGED1). Bound antibodies were visualized using the
Western Lightning Plus-ECL (Perkin-Elmer). ImageJ (NIH) was
used to quantify individual bands by normalizing the density of the
target band (MAGED1 or PARD6G) by the density of the ß-
ACTIN band for each sample.
Analysis of gene expression
Total RNA was isolated using RNeasy Mini-Kit (Qiagen)
according to manufacturer’s instructions followed by genomic
DNA decontamination using DNA-free kit (Applied Biosystems)
according to manufacturer’s directions. cDNA was synthesized
using the High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems) according to manufacturer’s instructions using C1000
Thermal Cycler (Bio-Rad). Quantitative real-time PCR (qPCR) was
performed on 50 ng cDNA template, 10 uM each forward and
reverse primer, and SensiMix Plus SYBR kit (Quantace) according
to manufacturer’s directions in 20 ul total volume using an ABI
7900 thermocycler. The following primer sets were used (all
sequences 59-39): Maged1–F, AGATGGCTCCCAGACTCAGA;
Maged1–R, CCTTTGATCCCCACTGTTGT; Pard6g–F, TGA-
CGACAACTTCTGCAAGG; Pard6g–R, GCTCCGAAGCTG-
TAATGGTC; Sfrp1-F, TACCACGGAAGCCTCTAAGC; Runx
2-F, ACAGTCCCAACTTCCTGTGC; Runx2-R, CACAGTCC-
CATCTGGTACCTC; Sfrp1-R, TCGCTTGCACAGAGAT-
GTTC; Sp7–F, TGCCCCAACTGTCAGGAG; Sp7–R,
GATGTGGCGGCTGTGAAT; Akp2–F, CCTTGAAAAATGC-
CCTGAAA; Akp2–R, TTACTGTGGAGACGCCCATA; Ibsp-F,
GAGGAGACTTCAAACGAAGAGG; Ibsp-R, ACACCCGA-
GAGTGTGGAAAG; Col1a1-F, CCCAAGGAAAAGAAGCAC-
GTC; Col1a1-R, AGGTCAGCTGGATAGCGACATC; Bglap2–
F, GAACAGACAAGTCCCACACAGC; Bglap2–R, AGAGACA-
GAGCGCAGCCAG; 36B4-F, ACTGAGATTCGGGATATG-
CTGT; 36B4-R, TCCTAGACCAGTGTTCTGAGCTG. Rela-
tive quantification was determined by the 2(2Delta Delta CT))
method using the 36B4 gene as reference gene [63]. The results
were obtained from N=4 independent experiments.
Microarray analysis of transfected pcOBs
Microarray expression profiles were generated using the
MouseWG-8v2 BeadChips (Illumina, San Diego, CA). Briefly,
biotin-16-UTP labeled cRNA was synthesized using the Illumina
TotalPrep RNA Amplification Kit (Ambion, Austin, TX). A total
of 850 ng of cRNA was then hybridized to the Illumina
BeadChips. Microarrays were scanned using the Illumina iScan
system and background corrected signal intensities were extracted
using the GenomeStudio software (Illumina). The lumi R package
was used to transform the data using a Variance Stabilizing
Transformation (VST) and normalized using quantile normaliza-
tion [64].
Osteoblast proliferation and differentiation assays
Proliferation was measured in pcOBs by plating cells at a
density of 2000 cells/dish in 96 wells, treating as indicated and
proliferation rate was determined using the BrdU ELISA assay
(Roche). The results were obtained from N=6 independent
experiments. Quantitative analysis of soluble alkaline phosphatase
activity in cell extracts was performed using a colorimetric kit
(AnaSpec) that measures the conversion of p-nitrophenyl phos-
phate to p-nitrophenol according to the manufacturer’s instruc-
tions. Alkaline phosphatase activity was normalized to protein
concentration. Protein levels were determined using using the
bicinchoninic acid (BCA) assay according to the manufacturer’s
instructions (Pierce). Mineralized nodule formation was measured
by staining cultures at 12 days post-differentiation with Alizarin
Red (40 mM) (pH 5.6). The stained cells were imaged and nodule
number was measured using ImageJ (NIH). Alizarin Red was
quantified by destaining cultures with 10% Acetic Acid and
determining the optical density (405 nM) of the resulting solution.
The results were obtained from N=4 independent experiments.
Supporting Information
File S1 Module assignments for all network probes. This file
contains the module assignments and annotations for each of the
13,579 microarray probes contained in the bone co-expression
network. Columns A–F provide probe annotations. Column G
contains the module assignments and columns H-AB contain the
correlation between each genes expression and module eigengene
for each of the 21 modules. This correlation is the kme for genes
within a given module.
(CSV)
File S2 Significant (FDR,0.05) gene ontology enrichments for
all 21 modules. This file is the output from DAVID and contains
(FDR,0.05) GO and KEGG ontology enrichments for each
module. For each module, columns B and C define the enriched
term. Column C–K contains, the number of module genes in each
category (Count), the percentn of module genes in each category
(Percent), the raw enrichment P-value (P-value), gene IDs, the total
number of genes in each category (List.Total), the total number of
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genes in the genome in each category (Pop.Hits) and the total
number of genes in the genome used to calculate each categories
enrichment (Pop.Total). Columns L, M and N contain P-values
adjusted for multiple comparisons using Bonferroni, Benjamini
and FDR corrections. More information about the output can be
found at (http://david.abcc.ncifcrf.gov/).
(CSV)
File S3 Additional siRNA controls. We knocked down the
expression of Kdelr3 (a member of M9 and a gene expressed in
osteoblasts) in primary calvarial osteoblasts as described in
methods. Its knockdown using two independent siRNAs resulted
in .95% knockdown (*P,0.05). Its knockdown did not alter
mineralized nodule formation. This confirms activation of the
RNA-induced silencing complex (RISC) and that the effects of
Maged1 and Pard6g knockdown are not due to an alteration in
overall cell function.
(PDF)
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